Beacon Harbor Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Beacon Harbor Wealth Advisors's BMY Position: Q2 2026 in Review
Beacon Harbor Wealth Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 146,238 shares worth $9.55M. The stake represents 1.86% of the portfolio and ranks #15 among its holdings. This is a return to the name: Beacon Harbor Wealth Advisors previously reported a position in BMY as recently as Q2 2025.
Beacon Harbor Wealth Advisors first reported a position in BMY in Q3 2019 and has held it in 18 quarters since. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Beacon Harbor Wealth Advisors held 146,238 shares of Bristol-Myers Squibb worth $9.55M as of Q2 2026.
- Bristol-Myers Squibb was a new Beacon Harbor Wealth Advisors position in Q2 2026.
- Bristol-Myers Squibb made up 1.86% of Beacon Harbor Wealth Advisors's portfolio in Q2 2026, its #15 holding.
- Beacon Harbor Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 18 quarters since.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Beacon Harbor Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.